Search Results 51-60 of 16593 for Certolizumab

  1. Filgotinib In The Induction And Maintenance Of Remission In Adults With Moderately To Severely Active Ulcerative Colitis - Mayo Clinic

    Prior use of any TNFα antagonist including (but not limited to) infliximab, adalimumab, golimumab, certolizumab, or biosimilar agents at any time. Prior or ...

  2. Infliximab (intravenous route) - Mayo Clinic

    Azathioprine; Bacillus of Calmette and Guerin Vaccine, Live; Baricitinib; Brodalumab; Certolizumab Pegol; Cholera Vaccine, Live; Cyclosporine; Dengue ...

  3. Biological Therapy For Cancer Clinical Trials - Mayo Clinic Research

    This study will test a study drug called cemiplimab to see if it can help treat early-stage cutaneous squamous cell carcinoma (CSCC), a type of skin cancer.

  4. A Study Of The Effectiveness And Safety Of Vedolizumab Compared To Adalimumab For Participants With Ulcerative Colitis - Mayo Clinic

    The purpose of this study is to evaluate the effectiveness and safety of vedolizumab intravenous (IV) treatment compared to adalimumab subcutaneous (SC) ...

  5. Targeted Drug Therapy Clinical Trials - Mayo Clinic Research

    Among persons with Immunoglobulin G subclass 4 Related Disease (IgG4)-related disease who have persistent or recurrent disease despite standard therapies, does ...

  6. Rituximab-pvvr (intravenous route) - Mayo Clinic

    Certolizumab Pegol; Cholera Vaccine; Cisplatin; Ebola Zaire Vaccine, Live; Infliximab; Influenza Virus Vaccine, Live; Rotavirus Vaccine, Live; SARS-COV-2 (COVID ...

  7. Inflammatory Bowel Disease Clinical Trials - Mayo Clinic Research

    The purpose of this study assess the current patient practice (standard of care) on Health Related Quality of Life (HRQOL), perceived stress level and disease ...

  8. Oncology (Medical) - Clinical trials

    The primary objective of the study is to compare sacituzumab tirumotecan combined with pembrolizumab to pembrolizumab alone with respect to overall survival ...

  9. Non-Hodgkin's Lymphoma Clinical Trials - Mayo Clinic Research

    Duvelisib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Chemotherapy drugs, such as CC-486, cyclophosphamide, ...

  10. Rituximab and hyaluronidase human, recombinant (subcutaneous route) - Side effects & uses - Mayo Clinic

    Benzocaine; Bupivacaine; Bupivacaine Liposome; Butacaine; Certolizumab Pegol; Chloroprocaine Hydrochloride; Cholera Vaccine; Cholera Vaccine, Live; Cisplatin ...